Founders Fund V Management

Latest statistics and disclosures from Founders Fund V Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CYTH, NVMI, RGTI, UBX, and represent 100.00% of Founders Fund V Management's stock portfolio.
  • Added to shares of these 1 stock: NVMI (+$209M).
  • Started 1 new stock position in NVMI.
  • Founders Fund V Management was a net buyer of stock by $209M.
  • Founders Fund V Management has $1.1B in assets under management (AUM), dropping by 15.49%.
  • Central Index Key (CIK): 0001697733

Tip: Access up to 7 years of quarterly data

Positions held by Founders Fund V Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Founders Fund V Management

Founders Fund V Management holds 4 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cyclo Therapeutics Com New (CYTH) 61.1 $668M 481k 1390.00
 View chart
NOVA MEASURING Instruments L (NVMI) 19.1 $209M NEW 118k 1770.00
 View chart
Rigetti Computing Common Stock (RGTI) 12.4 $136M 89k 1530.00
 View chart
Unity Biotechnology Com New (UBX) 7.4 $81M 49k 1640.00
 View chart

Past Filings by Founders Fund V Management

SEC 13F filings are viewable for Founders Fund V Management going back to 2020